Establishment and Evaluation of Clinical Prognostic Model of Hepatocellular Carcinoma Based on Pyroptosis-Related Genes

Abstract

Abstract:

〔Abstract〕 Objective： To explore the pyroptosis-related genes（PRGs） that are closely related to the prognosis of hepatocellular carcinoma（HCC）， and construct a corresponding prognostic risk model to evaluate the survival and prognosis of HCC patients. Methods： The transcriptome data and clinical data of HCC were downloaded from TCGA database， and the differentially expressed PRGs were screened out. COX analysis was used to determine the PRGs related to the prognosis of HCC and construct a prognostic risk score model， while K-M survival curve， receiver operator characteristic curve（ROC curve） and nomogram were plotted to analyze and verify the accuracy of the model and its prognostic value. Results： 58 differentially expressed PRGs were screened. GO function enrichment analysis showed that these genes were involved in pyroptosis， and KEGG signal pathway analysis showed that these genes were mainly enriched in non-alcohdic fatty liver disease and Toll-like receptor signal pathways. Eight PRGs significantly related to the prognosis of HCC were identified by COX analysis， and a prognostic risk score model was constructed. ROC curve showed that the area under the curve value of this risk score was 0.802， which was higher than other clinical data and could be as an independent prognostic factor. Conclusion： The prognostic risk model constructed by 8 PRGs can effectively predict the prognosis of patients with HCC.

Key words:

"> font-size:10.5pt, ">hepatocellular carcinoma, pyroptosis-related genes, prognostic model, TCGA database, bioinformaticsfont-size:10.5pt, ">

CLC Number:

Liu Chuanming, Li Xie, Lu Xikui, Zeng Diandian, Chen Jie.

Establishment and Evaluation of Clinical Prognostic Model of Hepatocellular Carcinoma Based on Pyroptosis-Related Genes [J]. Journal of Dali University, 2022, 7(10): 52-59.

References

〔1〕 SUNG H， FERLAY J， SIEGEL R L， et al. Global Cancer Statistics 2020： GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries〔J〕. CA Cancer J Clin， 2021， 71（3）： 209-249.

〔2〕 ZHANG Y S， GAO J Y， BAO Y， et al. Diagnostic Accuracy and Prognostic Significance of Osteopontin in Liver Cirrhosis and Hepatocellular Carcinoma：Ａ Meta-Analysis〔J〕. Biomarkers， 2022， 27（1）： 13-21.

〔3〕 DUNN J H， ELLIS L Z， FUJITA M. Inflammasomes as Molecular Mediators of Inflammation and Cancer： Potential Role in Melanoma〔J〕. Cancer Lett，2012，314（1）：24-33.

〔4〕田风，乔静，陈雪阳，等. 细胞焦亡的分子机制及其与恶性肿瘤的关系〔J〕. 中国肿瘤临床， 2020， 47（13）： 682-688.

〔5〕 LIN W L， CHEN Y， WU B M， et al. Identification of the Pyroptosis-Related Prognostic Gene Signature and the Associated Regulation Axis in Lung Adenocarcinoma〔J〕. Cell Death Discov， 2021， 7（1）： 161.

〔6〕 YE Y， DAI Q J， QI H B. A Novel Defined Pyroptosis-Related Gene Signature for Predicting the Prognosis of Ovarian Cancer〔J〕. Cell Death Discov， 2021， 7（1）： 71.

〔7〕应乐倩，王德强，余晖，等. 基于细胞焦亡与炎症反应相关基因构建肝细胞癌预后风险评估模型及验证〔J〕. 浙江医学， 2022， 44（3）： 250-257.

〔8〕 WU Z Y， CHEN L L， JIN C J， et al. A Novel Pyroptosis-Associated Gene Signature for Immune Status and Prog-nosis of Cutaneous Melanoma〔J〕. PeerJ，2021，9： e12304.

〔9〕 GAO L L， LI Q. Identification of Novel Pyroptosis-Related lncRNAs Associated with the Prognosis of Breast Cancer through Interactive Analysis〔J〕. Cancer Manag Res， 2021，13： 7175-7186.

〔10〕 DONG Z， BIAN L， WANG M L， et al. Identification of a Pyroptosis-Related Gene Signature for Prediction of Ove-rall Survival in Lung Adenocarcinoma〔J〕. J Oncol， 2021，2021： 6365459.

〔11〕 SONG W， REN J， XIANG R S， et al. Identification of Pyroptosis-Related Subtypes， the Development of A Prog-nosis Model， and Characterization of Tumor Microen-vironment Infiltration in Colorectal Cancer〔J〕. Oncoim-munology， 2021， 10（1）： 1987636.

〔12〕 LIU R， WANG G， ZHANG C， et al. A Prognostic Model for Hepatocellular Carcinoma Based on Apoptosis-Related Genes〔J〕. World J Surg Oncol， 2021， 19（1）： 70.

〔13〕 GRASS G D， DAI L， QIN Z Q， et al. CD147： Regulator of Hyaluronan Signaling in Invasiveness and Chemore-sistance〔J〕. Adv Cancer Res， 2014， 123： 351-373.

〔14〕 GALLAGHER S M， CASTORINO J J， PHILP N J. Interaction of Monocarboxylate Transporter 4 with Beta1-Integrin and Its Role in Cell Migration〔J〕. Am J Physiol Cell Physiol， 2009， 296（3）： C414-C421.

〔15〕 KANEKURA T， CHEN X. CD147/Basigin Promotes Pro-gression of Malignant Melanoma and other Cancers〔J〕. J Dermatol Sci， 2010， 57（3）： 149-154.

〔16〕 SUN J， HEMLER M E. Regulation of MMP-1 and MMP-2 Production through CD147/Extracellular Matrix Metal-loproteinase Inducer Interactions〔J〕. Cancer Res， 2001， 61（5）： 2276-2281.

〔17〕 TANG Y， NAKADA M T， KESAVAN P， et al. Extra-cellular Matrix Metalloproteinase Inducer Stimulates Tumor Angiogenesis by Elevating Vascular Endothelial Cell Growth Factor and Matrix Metalloproteinases〔J〕. Cancer Res， 2005， 65（8）： 3193-3199.

〔18〕 XU Z H， LIU R T， HUANG L， et al. CD147 Aggravated Inflammatory Bowel Disease by Triggering NF-κB-Medi-ated Pyroptosis〔J〕. Biomed Res Int， 2020， 2020： 5341247.

〔19〕 JING J S， WANG S C， MA J M， et al. Elevated CTSL2 Expression Is Associated with an Adverse Prognosis in Hepatocellular Carcinoma〔J〕. Int J Clin Exp Pathol， 2018，11（8）： 4035-4043.

〔20〕 LENG Y P， CHEN R F， CHEN R T， et al. HMGB1 Mediates Homocysteine-Induced Endothelial Cells Pyrop-tosis via Cathepsin V-Dependent Pathway〔J〕. Biochem Biophys Res Commun， 2020， 532（4）：640-646.

〔21〕 SHI F， CAO S L， ZHU Y H， et al. High Expression of DHX9 Promotes the Growth and Metastasis of Hepatocellular Carcinoma〔J〕. J Clin Lab Anal， 2021， 35（12）： e24052.

〔22〕 BRIARD B， PLACE D E， KANNEGANTI T D. DNA Sensing in the Innate Immune Response〔J〕. Physiology （Bethesda）， 2020， 35（2）： 112-124.

〔23〕 XU D F， WANG Y， ZHOU K L， et al. Development and Validation of A Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma〔J〕. Onco Targets Ther， 2020， 13： 8125-8140.

〔24〕 SUZUKI S，SUZUKI T，MIMURO H，et al. Shigella Hijacks the Glomulin-cIAPs-Inflammasome Axis to Promote Inflammation〔J〕. EMBO Rep， 2018， 19（1）： 89-101.

〔25〕 GUO X X， LI X P， ZHOU P， et al. Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Sup-pressing NOD1 Signal Pathway〔J〕. Int J Mol Sci， 2018， 19（11）： 3419.

〔26〕 KUMAR V， KUMAR A， MIR K U I， et al. Pleiotropic Role of PARP1： An Overview〔J〕. 3 Biotech， 2022， 12（1）： 3.

〔27〕 NOMURA F， YAGUCHI M， TOGAWA A， et al. Enhan-cement of Poly-Adenosine Diphosphate-Ribosylation in Human Hepatocellular Carcinoma〔J〕. J Gastroenterol Hepatol， 2000， 15（5）： 529-535.

〔28〕 SINGH N. Enhanced Poly ADP-Ribosylation in Human Leukemia Lymphocytes and Ovarian Cancers〔J〕. Cancer Lett， 1991， 58（1/2）： 131-135.

〔29〕 YALCINTEPE L，TURKER-SENER L，SENER A，et al. Changes in NAD/ADP-Ribose Metabolism in Rectal Cancer〔J〕. Braz J Med Biol Res， 2005， 38（3）：361-365.

〔30〕刘梅，黄晶，王军，等. 碘化钾通过诱导PARP1表达活化NF-κB/NLRP3炎症小体促进甲状腺滤泡细胞焦亡〔J〕. 中华内分泌代谢杂志， 2021， 37（9）： 820-829.

〔31〕 ICHIMURA Y，WAGURI S，SOU Y S，et al. Phospho-rylation of P62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy〔J〕. Mol Cell， 2013， 51（5）： 618-631.

〔32〕 SAITO T， ICHIMURA Y， TAGUCHI K， et al. P62/Sqstm1 Promotes Malignancy of HCV-Positive Hepa-tocellular Carcinoma through Nrf2-Dependent Metabolic Reprogramming〔J〕. Nat Commun， 2016， 7： 12030.

〔33〕 SUN H F， FENG J G， TANG L L. Function of TREM1 and TREM2 in Liver-Related Diseases〔J〕. Cells， 2020， 9（12）： 2626.

〔34〕 RAMACHANDRAN P， DOBIE R， WILSON-KANAMO-RI J R， et al. Resolving the Fibrotic Niche of Human Liver Cirrhosis at Single-Cell Level〔J〕. Nature， 2019， 575（7783）： 512-518.

〔35〕 YE Y， SONG Y N， ZHUANG J H， et al. Anticancer Effects of Echinacoside in Hepatocellular Carcinoma Mouse Model and HepG2 Cells〔J〕. J Cell Physiol， 2019， 234（2）： 1880-1888.

[1]	Xie Diyang, Peng Zhijie. On the Extraterritorial Jurisdiction in the International Environmental Civil Public Interest Litigation [J]. Journal of Dali University, 2022, 7(7): 46-55.
[2]	Zhang Huan. The Dilemma and Outlet of Cambodian Chinese Education under the Background of Belt and Road Initiative [J]. Journal of Dali University, 2022, 7(7): 104-108.
[3]	Ou Ling, Li Cailin, Li Yinrui, Zhou Jie, Shan Wanxin, Wu Dingyu, Peng Fang. In vitro Study on the Periplaneta americana Polypepticde PAE2 Reversing Multi-Drug Resistance of BEL-7402/5-FU Based on AMPK-Regulated Autophagy [J]. Journal of Dali University, 2022, 7(4): 1-7.
[4]	Qing Chen, Chen Jinghu, Li Bolong, Liu Heng, Zhang Chenggui. Comparative Analysis of Liposoluble Constituents in the Larvae and Adults of Black Soldier Fly by GC-MS [J]. Journal of Dali University, 2022, 7(4): 8-11.
[5]	Wang Ruihang, Liu Xiaobo, Liao Ｓi, Hua Peng. Meta-Analysis of Cutaneous Adverse Reactions Induced by Dabrafenib Combined with Trametinib in the Treatment of Melanoma [J]. Journal of Dali University, 2022, 7(4): 12-20.
[6]	Hong Wenjuan, Zou Jiulin, Yu Zhuorui, Cheng Jiamao, He Minhua. Effects of SGLT2i on Bone Metabolism in Nephrotic Syndrome Model Rats [J]. Journal of Dali University, 2022, 7(4): 21-25.
[7]	Li Bin, Li Sufen, Yang Na, Xiong Wei. Expression and Significance of THBS2 Gene mRNA in Human Malignant Pleural Mesothelioma Based on Tumor Databases [J]. Journal of Dali University, 2022, 7(4): 26-33.
[8]	Duan Yi, Ni Changwen, Wang Minhua, Sun Sujiao, Huang Ling. Effects of the 7-Hydroxyisoflavone in the Proliferative Activity of HaCaT Cells and UVB-induced Photodamage [J]. Journal of Dali University, 2022, 7(4): 34-39.
[9]	Huang Zhong, Jia Ruipeng, Liu Yiheng, Zhang Chao, Liu Ke. Analysis of Risk Factors for Bone Cement Leakage during Percutaneous Kyphoplasty [J]. Journal of Dali University, 2022, 7(4): 40-43.
[10]	Luo Xinlei, Zhao Hui, Bai Tao, Xu Song, Zhang Xiongwen, Na Qiang. Analysis of Influencing Factors of New Fractures after Osteoporotic Vertebral Compression Fracture Surgery [J]. Journal of Dali University, 2022, 7(4): 44-46.
[11]	Xu Sanxiong, Zhang Jiyuan, Ma Xueying, Wei Guosong, Li Lin. Comparison of Curative Effects of MIS-TLIF and PLIF in the Treatment of Single-Segment Lumbar Degenerative Diseases [J]. Journal of Dali University, 2022, 7(4): 47-51.
[12]	Liu Siyuan, Rao Tao, Zhao Heng, Dou Jichen, Zhou Yi, Liu Qinghua, Cun Ｘinhua, . Clinical Evaluation of Oblique Lateral Interbody Fusion in the Treatment of Elderly Patients with Lumbar Tuberculosis [J]. Journal of Dali University, 2022, 7(4): 52-56.
[13]	Hu Jianhua, Hu Qi, Gao Guoxi, Lian Xingye, Yang Zhao, Zhang Chao. Analysis of the Treatment of Early Incision Deep Infection after Posterior Lumbar Internal Fixation and Fusion [J]. Journal of Dali University, 2022, 7(4): 57-59.
[14]	Gao Guoxi, Lian Xingye, Liu Weibing, Zhang Jun, Hu Jianhua, Lei Yunkun, Yang Zhao, Zhang Chao. Analysis of Clinical Treatment of Lumbar Brucellosis [J]. Journal of Dali University, 2022, 7(4): 60-62.
[15]	Peng Yunchuan, Luo Ting, Qi Lin, Ma Hongbing. Clinical Application of Improved Preoperative Preparation Method for DAA Total Hip Arthroplasty [J]. Journal of Dali University, 2022, 7(4): 63-65.